The human peptidyl-prolyl isomerase Pin1 was first isolated for its ability to interact with NIMA protein kinase in the two-hybrid system (1) . Pin1 is an 18-kDA protein with orthologs that have been identified in yeast, Drosophila, Xenopus, fungi, mice, and plants (2) (3) (4) (5) (6) (7) (8) . Pin1 belongs to the parvulin family of isomerases, which is distinct from the cyclophilin and FK506 binding protein peptidyl-prolyl isomerase families. Studies on Pin1 provide evidence for its involvement in the G 2 /M transition and in mitosis. Pin1 can interact with many mitotic regulators including Myt1, Wee1, Plk1/Plx1, and Cdc25, although not with Cdc2 (8 -10) . Overexpression of Pin1 in HeLa cells resulted in a G 2 arrest, whereas depletion of Pin1 in HeLa cells and yeast led to a mitotic arrest (1) . Two groups found that the addition of recombinant Pin1 to cycling Xenopus extracts in vitro stopped extracts from entering mitosis (8, 9) . Additionally, Winkler et al. (11) observed that interphase Xenopus egg extracts depleted of the Xenopus Pin1 homolog, xPin1, entered mitosis more rapidly than controls. They also clearly demonstrated that xPin1 is required for the execution of the DNA replication checkpoint. Collectively, these results link Pin1 to the G 2 /M transition and events regulating mitosis.
Another important protein implicated in cell cycle events and in cell viability is the highly conserved Ser/Thr protein kinase CK2, 1 a tetrameric enzyme that is composed of two catalytic (CK2␣ and/or CK2␣Ј) subunits and two regulatory (CK2␤) subunits (reviewed in Refs. [12] [13] [14] [15] [16] . Genetic studies in yeast suggest a role for CK2 at distinct stages during cell cycle progression including the G 2 /M transition where it is required for the phosphorylation of topoisomerase II (12, 17) . In mammalian cells, CK2 activity increases when quiescent cells are stimulated to proliferate (reviewed in Refs. [13] [14] [15] [16] . Studies performed using selective CK2 inhibitors, antisense down-regulation, or kinase-inactive mutants of CK2 also illustrate that CK2 is required during various stages of cell cycle progression including the G 2 /M transition and in checkpoint control (18 -20) . Moreover, CK2 activity levels are elevated in a number of tumors and leukemic cells. Targeted overexpression of CK2 in transgenic mice results in the development of T cell lymphoma and mammary tumorigenesis (21, 22) . Additionally, accelerated lymphomagenesis is observed when mice with elevated expression of CK2 in T cells are crossed with transgenic mice overexpressing c-Myc or Tal-1 or in mice that are deficient in p53 (21, 23, 24) . Collectively, these studies implicate CK2 as an important component of signaling pathways involved in cell cycle progression and transformation.
Although the mechanism of CK2 regulation is not fully understood, one way in which it could be regulated is through phosphorylation. Several sites on CK2 are known to be phosphorylated in cells (25) (26) (27) (28) . In fact, in light of its predicted involvement in various aspects of cell cycle progression, it is notable that CK2 is phosphorylated in a cell cycle-dependent manner (26) . In particular, one isoform of the CK2 catalytic subunit (i.e. CK2␣) is selectively phosphorylated in mitotic cells at 4 sites localized within its C-terminal 60 amino acids. Interestingly, the other isoform of the CK2 catalytic subunit (i.e. CK2␣Ј) has a distinct C-terminal domain that lacks these phosphorylation sites and is not phosphorylated in mitotic cells (26) . The mitotic phosphorylation sites on CK2␣ can all be phosphorylated in vitro by p34 Cdc2 , suggesting that this enzyme is responsible for the mitotic phosphorylation of CK2 and that CK2 is a participant in a p34
Cdc2 -mediated protein kinase cascade. Identification of the sites that are phosphorylated by p34
Cdc2 revealed that the mitotic phosphorylation sites on CK2␣ (Thr-344, Thr-360, Ser-362, and Ser-370) can all be classified as proline-directed phosphorylation sites because each of the phosphorylated residues is immediately N-terminal to a proline (28) . The regulatory ␤ subunit of CK2 is also phosphorylated at autophosphorylation sites and at a site that is maximally phosphorylated in mitotic cells (26) . Despite the identification of these phosphorylation sites, no clear effect of phosphorylation of CK2 on CK2 activity has yet been observed (29) . Because the mitotic phosphorylation sites on CK2 are all Ser-Pro or Thr-Pro sites that resemble the optimal binding motif for Pin1 (30) , we hypothesized that CK2 may interact with Pin1 in a phosphorylation-dependent manner as a part of events regulating the cell cycle. Experiments described in this paper were undertaken to test for an interaction between Pin1 and CK2 and for the phosphorylation dependence of this interaction. Furthermore, having demonstrated interactions between CK2 and Pin1, we examined the effects of Pin1 on CK2 activity toward several substrates. Of particular interest was topoisomerase II, a protein that is important for cell cycle progression. At the non-permissive temperature, yeast with temperature-sensitive CK2 fail to enter mitosis (12, 27, 31) . In these yeast, topoisomerase II is hypo-phosphorylated and inactive, suggesting that it is a bona fide physiological target for CK2. Additionally, it was recently demonstrated in mammalian cells that CK2 phosphorylates residues on topoisomerase II␣, including Thr-1342, which are residues that are maximally phosphorylated in mitotic cells (32) (33) (34) . In this study, we demonstrated that Pin1 inhibits the in vitro phosphorylation of Thr-1342 on topoisomerase II␣ by CK2 and that Pin1 interacts with topoisomerase II␣. Maximal inhibition of phosphorylation of Thr-1342 by CK2 requires full-length Pin1 with intact WW and isomerase domains.
MATERIALS AND METHODS
DNA Constructs-CK2 constructs had HA or Myc tags to allow the identification or isolation of transfected CK2 subunits from endogenous CK2 subunits. As described previously (35) , the HA tag consists of three repeats of the influenza hemagglutinin epitope YPYDVPDY, and the Myc tag consists of the Myc epitope MASMEQKLISEEDLNN. Constructs encoding CK2␣ with a C-terminal HA tag were generated using pRc/CMV (Invitrogen). The following CK2␣ constructs were employed: wild-type ␣-HA, ␣-4A-HA, ␣-4D-HA, and ␣-4E-HA. In these latter three constructs, the four mitotic phosphorylation sites on CK2␣, (i.e. Thr-344, Thr-360, Ser-362, and Ser-370) were mutated to alanines, aspartic acids, and glutamic acids, respectively, by using sequential PCR. All constructs were verified by sequencing.
The CK2␣Ј subunit was HA-tagged at its N terminus and was also expressed using pRc/CMV (Invitrogen). In addition to wild-type CK2␣Ј, a construct encoding a chimera consisting of the N-terminal domain of CK2␣Ј with the C-terminal domain of CK2␣, as described previously (35) , was utilized. The latter chimeric construct encodes residues 1-296 of CK2␣Ј together with the C-terminal fragment of CK2␣ (i.e. residues 296 -391 of CK2␣) instead of the natural C terminus of CK2␣Ј (i.e. residues 297-350 of CK2␣Ј). Generation of the chimeric construct was described previously (35) and was achieved using a Bsu36I restriction site that is conserved between CK2␣ and CK2␣Ј. Importantly, the four mitotic phosphorylation sites on CK2␣ (i.e. Thr-344, Thr-360, Ser-362, and Ser-370) are all located with the C-terminal portion of CK2␣ that was transferred to CK2␣Ј to generate the chimera. Constructs encoding CK2␤ subunits had N-terminal Myc tags and were also in pRc/CMV. In addition to wild-type Myc-CK2␤, constructs were generated to encode Myc-CK2␤ with mutations at its mitotic phosphorylation site at Ser-209. For these constructs, Ser-209 was mutated to alanine (i.e. Myc-␤S209A) or to aspartic acid (i.e. Myc-␤S209D). All constructs were verified by sequencing.
Several DNA constructs were made for use in the production of recombinant GST-Pin1 fusion proteins. GST fusion proteins were generated using the pGEX-KG (36) vector. The Pin1 cDNA was obtained from American Type Culture Collection (ATCC 928227). It was amplified by PCR to introduce NcoI and HindIII restriction sites to the 5Ј and 3Ј end, respectively, of the Pin1 coding region to facilitate subcloning. Primers for PCR were as follows: GGA TCC CCA TGG CGG ACG AGG AGA AGC TG (forward primer designated p1) and GGA TCC AAG CTT CAC TCA GTG CGG AGG ATG ATG (reverse primer designated p2). The PCR product (ϳ490 bp) was ligated into PCR-Blunt (Invitrogen) and sequenced. The modified Pin1 cDNA was then subcloned into pGEX-KG using the NcoI and HindIII sites to generate pGEX-KG-Pin1.
Four mutant GST-Pin1 constructs were also generated. GSTPin1
Y23A and GST-Pin1 R68A,R69A are full-length GST-Pin1 fusion proteins with point mutations resulting in the loss of WW binding ability (37) and a dramatic decrease in isomerase activity (9, 30) , respectively. GST-Pin1-(1-54) encodes a GST fusion protein with the WW domain of Pin1 and GST-Pin1-(47-163) is a GST fusion protein encoding only the peptide prolyl isomerase domain of Pin1 (37) . Pin1   Y23A   and  Pin1 R68A,R69A were also made by sequential PCR. In the first round for Pin1 Y23A , primer pairs p-1 with p-3 (TTG AAG TAG GCC ACT CGG CCT GAG CT) and p-2 with p-4 (CCG AGT GGC CTA CTT CAA CCA CAT) were used. Likewise, for Pin1 R68A,R69A primers p-1 with p-5 (CGA GGG TGC TGC TGA CTG GCT GTG C) and p-2 with p-6 (AAG CAC AGC CAG TCA GCA GCA CCC TCG TCC T) were used. For the second round of PCR, primers p-1 and p-2 were used for both fragments. Pin1-(1-54) encompassing the WW domain of Pin1 was created using primers p-1 and p-8 (GGA TCC AAG CTT CCT GGC AGG CTC CC) and Pin1-(47-163) with primers p-7 (TGG CCT TGG CTG AGC TGC AGT) and p-9 (GGA TCCATG GCAAAC GGG CAG GGG GAG). All of these final PCR products were then separately ligated into PCR-Blunt. Fragments encoding Pin1-(47-163), Pin1
Y23A
, and Pin1 R68A,R69A in PCRBlunt were digested with NcoI and HindIII yielding the desired fragments of ϳ340, 490, and 490 bp, respectively. These NcoI/HindIII fragments were then used to replace NcoI/HindIII fragments from the Pin1 in pGEX-KG. For Pin1-(1-54), a 165-bp NcoI/BlpI fragment was isolated from the pCR-Blunt construct and subcloned into pGEX-KG vector that had been similarly digested. For the constructs described above in detail, all PCR amplifications were done using Pfu DNA polymerase (Stratagene) and sequenced by dideoxy sequencing (38) using T7 polymerase (Amersham Biosciences kit) or by ABI Prism BigDye Terminator method (PerkinElmer Life Sciences) at the Robarts Research Institute (Ontario, Canada). Sequencing and restriction digests were used to verify all constructs.
Plasmids encoding GST-C92, a GST fusion protein encoding the C-terminal 92 amino acids of c-Myc (39), GST-Max, a GST fusion protein encoding Max (40) , and GST-631, a GST fusion protein encoding the N-terminal 198 amino acids of c-Myb (41), were generous gifts of Dr. B. Luscher (Hannover, Germany).
Protein Production and Purification-GST, GST-Pin1, and GST-Pin1 mutant proteins were expressed in BL21 or DH5␣ bacteria grown in 2ϫ YT with 100 g/ml ampicillin (Roche Molecular Biochemicals) at 37°C. After cultures reached an absorbance of greater than 0.6 at 600 nm, isopropyl-␤-D-thiogalactoside (Indofine Chemical Corp.) was added to a final concentration of 0.1 mM. After 2-4 h, cells were pelleted, washed with PBS (130 mM NaCl, 3 mM KCl, 10 mM NaHPO 4 , 2 mM KH 2 PO 4 , pH 7.4), and then resuspended in PBS containing 1.5 g/ml aprotinin, 10 g/ml leupeptin, 100 M phenylmethylsulfonyl fluoride (PMSF) (Sigma) before being lysed using a French press or by sonication. Triton X-100 was added to this bacterial lysate to a final concentration of 1%, and the solution was incubated with continual mixing for 15-25 min at 4°C. Cell debris was pelleted by centrifugation at 6600 ϫ g. The supernatant was incubated with glutathione immobilized on agarose beads (Sigma) for 20 -60 min at 4°C or room temperature with continuous mixing. After thorough washing with PBS, the beads were used directly, or the protein was eluted using free glutathione (10 mM reduced glutathione (Sigma), 50 mM Tris-HCl, pH 8.0, 1 mM DTT). Eluted protein was dialyzed against 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, with or without 1 mM dithiothreitol (DTT) and stored at Ϫ80°C. Protein concentrations were determined using Coomassie protein assay (Pierce) and using bovine serum albumin as a standard.
Other GST fusion proteins that were used in kinase assays were similarly isolated. These included GST-C92 (39), a GST fusion protein encoding the C-terminal 92 amino acids of c-Myc, GST-Max (40), a GST fusion protein encoding Max, and GST-631 (41), a GST fusion protein encoding the N-terminal 198 amino acids of c-Myb. GST-CK2␣-C126 was expressed, purified, and phosphorylated with purified p34
Cdc2 using [␥-
32 P]ATP as described previously (28) . Cleavage of GST-Pin1 was achieved by incubating with thrombin (1:100) in 10 mM Tris, pH 7.4, 150 mM NaCl, 2.5 mM CaCl 2 , 2 mM DTT at 37°C. Pin1 was subsequently separated from the GST by FPLC using a Mono S (HR5/5) column. Briefly, thrombin cleaved GST, and Pin1 fractions were diluted with an equal volume of 50 mM Hepes, pH 7.5, 0.1 mM EDTA and applied to the Mono S column. GST was not retained in the column and appeared in the flow-through. Pin1 was retained on the column and eluted using a 0 -1 M NaCl gradient in 50 mM Hepes, pH 7.5, 0.1 mM EDTA. Fractions containing Pin1 were identified by SDS-PAGE and stored at Ϫ20°C.
Y2C, a 205-amino acid portion of the topoisomerase II␣ C terminus with a His tag to facilitate purification, and a mutant form of Y2C with a threonine to alanine substitution at residue 1342 were described previously (33) . The Y2C fragment encodes residues 1158 -1362 of topoisomerase II␣ and has a pI of 8.5 indicating an overall basic character. These proteins were expressed in BL21 bacteria grown in LB or 2ϫ YT with 50 g/ml kanamycin monosulfate (Sigma) at 37°C. After cultures reached an absorbance of greater than 0.4 at 600 nm, isopropyl-␤-D-thiogalactoside was added to a final concentration of 1 mM, and 3 h later the cells were pelleted. Cells were used directly or stored at Ϫ20°C. Proteins were harvested using a modified version of the manufacturer's recommendations using Ni-NTA Superflow beads (Qiagen). Briefly, pellets were thawed on ice for 15 min, resuspended in 8 M urea, 0.1 M NaH 2 PO 4 , 0.01 M Tris-Cl, pH 8.0, and incubated at room temperature for 15-60 min with gentle mixing. After centrifugation at 6,600 ϫ g for 20 -30 min, the supernatant was incubated with Ni-NTA Superflow beads for ϳ1 h with vigorous mixing. Beads were washed repeatedly with 8 M urea, 0.1 M NaH 2 PO 4 , 0.01 M Tris-Cl, pH 6.3. After removing the last wash, sample buffer (108 mM Tris, pH 6.8, 3.6% SDS, 18% glycerol, 0.01% bromphenol blue, 10% ␤-mercaptoethanol) was added to beads to release the Y2C proteins.
Pin1 with an N-terminal His tag and a fusion protein designated N70 encoding residues 1-610 of SecA also with an N-terminal His tag were obtained from Dr. K. Hamilton and Dr. B. Shilton, respectively (London, Ontario, Canada).
Antibodies-Polyclonal antipeptide antibodies directed against the N terminus of CK2␣ (residues 2-19), the C terminus of CK2␣ (residues 376 -391), the C terminus of CK2␣Ј (residues 333-350), and the C terminus of CK2␤ (residues 198 -215) have been described elsewhere (19, 42) . Polyclonal rabbit anti-mouse antibodies were the IgG fraction of antiserum purchased from Sigma. Monoclonal antibody 12CA5 (Babco) recognizes the HA epitope (43, 44) , and monoclonal antibody 9E10 recognizes the Myc epitope (45) . The anti-phosphoepitope monoclonal antibody 3F3/2 was described previously (33) . Anti-topoisomerase II Ab-1 (Calbiochem) is a monoclonal antibody directed against the C-terminal of human topoisomerase II␣. Biotin-conjugated anti-HA monoclonal (3F10) antibodies were purchased from Roche Molecular Biochemicals, and peroxidase-conjugated anti-biotin monoclonal antibodies were purchased from Jackson ImmunoResearch. Goat anti-rabbit and goat anti-mouse horseradish peroxidase and alkaline phosphatase-conjugated secondary antibodies were obtained from Bio-Rad.
Cell Culture and Transfections-U20S/UTA6 cells, a human osteosarcoma cell line with a tetracycline-regulated transcriptional activator fusion protein (generous gift from Dr. Christoph Englert, Froschungszentrum Karlsruhe, Germany (46)), were grown in Dulbecco's modified Eagle's medium with 10% fetal calf serum, 0.1 mg/ml streptomycin, and 100 units/ml penicillin (Invitrogen). Standard calcium phosphate transfections (47) were performed using 34 -40 g of DNA per 10-cm plate. Specifically 17 g of ␣ or ␣Ј constructs, 17 g of ␤ construct, and ϳ3.4 g of pEGFP-C2 (CLONTECH), pEGFP-C3 (CLONTECH), or ␤-galactosidase in pRc/CMV were used per 10-cm plate. The pEGFP or ␤-galactosidase plasmids were transfected into cells to monitor transfection efficiency by fluorescence microscopy or by 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-gal) staining, respectively. The following sequence of events was then performed: 14 -16 h after the DNA was added to the cells, the precipitate was washed and fresh media were added; 18 h later new media with a final concentration of 0.1 g/ml nocodazole (Sigma) was added to the plates to arrest cells in mitosis; a further 16 -18 h later okadaic acid (Calbiochem) was added to media to a final concentration of 1 M; and 2 h later the cells were harvested. For interphase cell populations the nocodazole and okadaic acid were not added.
Extact Preparation for GST and GST-Pin1 Binding Assays-After removing media from the tissue culture plates and washing twice with PBS, interphase cells were harvested by scraping in 500 l per 10-cm plate of Tris Lysis Buffer (50 mM Tris, pH 8.0, 1% Nonidet P-40, 150 mM NaCl) with 1 mM DTT, 1.5 g/ml aprotinin, 10 g/ml leupeptin, 100 M PMSF, and 1 M microcystin LR (Sigma). Mitotic cells were shaken off the plates by repeated pipetting of the media over the plate surface. The media were collected; the cells were pelleted by centrifugation, and the pellet was washed once with PBS. The cell pellet was then resuspended in a volume equivalent to 500 l of Tris Lysis Buffer per 10-cm plate harvested. Both interphase and mitotic cells were then sonicated for 30 s and then centrifuged at 107,700 ϫ g for 20 min at 4°C. The cell extract supernatants were then stored until use at Ϫ80°C. Protein determinations were performed using the BCA protein assay (Pierce) using bovine serum albumin as standard.
Interphase nuclear extracts and mitotic chromosome preparations to be used as a source of topoisomerase II␣ for GST and GST-Pin1 binding assays were isolated as described (33) . Prior to use in the binding assays, these preparations were subjected to DNase (Roche Molecular Biochemicals) treatment in the presence of 10 mM MgCl 2 and 5 mM CaCl 2 for 10 -20 min at room temperature.
Chromatographic Fractionation of Cell Extracts-Untransfected cells were used to prepare interphase and mitotic fractions containing CK2 to be used in kinase assays. To obtain mitotic extracts, cells were grown in media with 0.1 g/ml nocodazole for 16 -21 h. Interphase and mitotic cells were harvested as described above except using Buffer A (50 mM Tris-Cl, pH 7.5, 2 mM EDTA, 1 mM DTT, 50 mM NaCl) with 1.5 g/ml aprotinin, 10 g/ml leupeptin, 100 M PMSF, 1 M microcystin, and 10 mM NaF instead of Tris Lysis Buffer. Equal amounts of protein, as determined by Coomassie protein assay (Pierce), were loaded on an FPLC column. Chromatographic fractionation was performed with either a Amersham Biosciences Mono Q column 5 ϫ 50 mm on a Amersham Biosciences FPLC system or a Waters Protein Pak Q-8HR column on a Waters 625LC system. Protein was eluted using a 25-ml salt gradient starting with Buffer A and ending with Buffer B (50 mM Tris-Cl, pH 7.5, 2 mM EDTA, 1 mM DTT, 1 M NaCl) at a flow rate ranging from 0.25 to 0.5 ml/min. Eluted fractions were analyzed by SDS-PAGE followed by immunoblotting for the presence of CK2␣ and by kinase assays using a synthetic peptide to determine the amount of activity present in each fraction (as described below) (48) . Immunoblots also allowed for the examination of the phosphorylation state of CK2 because phosphorylation of CK2␣ results in a shift in electrophoretic mobility (26, 28) .
GST-Pin1 and His-Pin1 Binding Assays-For binding assays with GST fusion proteins, equal amounts of GST-Pin1 or GST were incubated with 20 l of a 1:1 slurry of glutathione-immobilized agarose beads to PBS for 20 min at 4°C with continual mixing. The beads were then washed 3 or 4 times with PBS and/or Tris Lysis Buffer. An aliquot of the cell extract (prepared as in described in section 2.5) was mixed 1:1 with sample buffer and set aside for the gel. In each binding assay, 20 l of 1:1 beads was incubated with 350 -600 l of the cell extract (typically 0.1-2 mg/ml) for 1 h at 4°C with continuous mixing. The beads were then washed three times with Tris Lysis Buffer. After the removal of the last wash, a 50-l sample buffer was added to the beads to elute bound proteins.
Binding assays with His-Pin1 were similarly performed by incubating His-Pin1 or N70 with Ni-NTA resin (Qiagen) according to the manufacturer's recommendations.
SDS-PAGE and Immunoblots-Proteins were separated on 6 or 12% SDS-PAGE gels and transferred to polyvinylidene difluoride membrane (Roche Molecular Biochemicals) as described by Towbin et al. (49) , over 1 h at 100 V in Blotting Buffer (25 mM Tris-Cl, pH 7.5, 190 mM glycine, 20% methanol). Prestained molecular weight markers (broad range from New England Biolabs) were used for reference. Markers and their molecular masses are as follows: 175-kDa MBP-␤-galactosidase, 83-kDa MBP-paramyosin, 62-kDa glutamic dehydrogenase, 47.5-kDa aldolase, 32.5-kDa triose-phosphate isomerase, 25-kDa ␤-lactoglobulin A, 16.5-kDa lysozyme, and 6.5-kDa aprotinin.
Immunoblots for colorimetric detection were treated in the following way: after washing in TBS (20 mM Tris-Cl, pH 7.5, 500 mM NaCl) the membranes were blocked for 30 -60 min with 3% gelatin in TBS, followed by a 1-h incubation in the primary antibody solution and then 30 -60 min in the secondary antibody solution. TBST (TBS with 0.05% Tween 20) was used to wash blots between incubations. Both primary and secondary antibodies were diluted in 1% gelatin in TBST. The dilutions of primary antibody used were as follows: 1:1000 for anti-␣, 1:500 for anti-␤, anti-HA, and anti-Myc. Alkaline phosphatase-conjugated goat anti-rabbit or goat anti-mouse antibodies (1:3000) were utilized as secondary antibodies. After the final TBST wash, the blots were washed with TBS and then incubated in a solution of 5-bromo-4-chloro-3-indoyl phosphate p-toluidine salt and p-nitro blue tetrazolium chloride (Bio-Rad) in AP Buffer (100 mM Tris-Cl, pH 9.5, 0.5 mM MgCl 2 ).
Immunoblots were similarly performed for chemiluminescent detection of HA-tagged CK2␣ with the following exceptions: blots were blocked with 2% bovine serum albumin (BSA) in PBS; all antibody solutions were made up in 1% BSA in PBST (PBS with 0.1% Tween 20); the primary antibody biotin-conjugated anti-HA was diluted 1:500; horseradish peroxidase-conjugated anti-biotin was diluted 1:20,000; washes were done with PBST; and in the last step blots were incubated in SuperSignal West Pico peroxide and luminal/enhancer solution (Pierce) and then exposed to x-ray film (Eastman Kodak). Immunoblots for the detection of topoisomerase II␣ from binding assays were processed similarly except that gelatin was used in the place of BSA and anti-topoisomerase II Ab-1 at 6.3 g/ml in 1% gelatin in TBST was used as the primary antibody.
Immunoblots with radioactive detection were performed as described above for colorimetric blots except that the secondary antibody used was the rabbit anti-mouse antibody diluted 1:11,000, and there was a third incubation after this with protein A-125 I (specific activity 70 -100 Ci/g, ICN) at 50,000 -100,000 cpm/ml in 1% gelatin in TBST for 1-4 h. After this the blot was washed extensively, air-dried, and visualized using a PhosphorImager (Molecular Dynamics).
Topoisomerase II Phosphorylation Assay-The topoisomerase II phosphorylation assay was performed as described in Daum and Gorbsky (33) . Briefly, the Y2C fragments of topoisomerase II␣ were run on SDS-PAGE gel and blotted as described above. The blots were cut into strips along the edge of the lanes. These blot strips were blocked in 3% gelatin in TBS for 15-30 min. Blots were washed once in TBST and again in TBST or TEM (50 mM Tris-HCl, pH 7.5, 10 mM EGTA, 4 mM MgSO 4 ). The blots were equilibrated in TEM with inhibitors (1.5 g/ml aprotinin, 10 g/ml leupeptin, 100 M PMSF, 1 mM DTT, and 200 or 400 nM microcystin), and then the kinase assay was performed. Blot strips were incubated in small trays with 1 mM ATP, column fractions containing purified CK2, and with GST or GST-Pin1 diluted in TEM with inhibitors for 20 -30 min at 30 -38°C. To halt the reaction, blot strips were washed four times with TBST. Blot strips were incubated with a 1:5000 dilution of 3F3/2 antibody in 1% BSA in TBST for 1 h, washed, incubated with goat anti-mouse horseradish peroxidase 1:15,000 in 1% BSA in TBST for 1 h, and finally incubated in the SuperSignal solution (Pierce). The activity of CK2 from FPLC fractions used in these assays ranged from 7 to 34 pmol/min/ml. The range of GST and GST-Pin1 concentrations used in these experiments was from 0 to 2 M.
CK2 Kinase Assays-CK2 kinase assays were performed using a synthetic peptide substrate, RRRDDDSDDD, as described previously (19, 48) . In brief, small aliquots (6 -12 l) of CK2 from the FPLC fractions were incubated with and without 0.1 mM peptide substrate in 20 mM Tris-Cl, pH 7.5, 60 mM NaCl, 10 mM MgCl 2 , 1 mM DTT, and 100 M [␥-32 P]ATP (specific activity 50 -100 cpm/pmol) for 5 and 10 min. The total reaction volume was 30 l. An aliquot of the mix was then spotted on P81 phosphocellulose paper, washed extensively with 1% phosphoric acid, washed once with 95% ethanol, and quantified using a scintillation counter or PhosphorImager. To examine the effects of Pin1 on CK2 activity, peptide phosphorylation assays were similarly performed in the presence of the indicated amount of GST or GST-Pin1 using FPLC fractions as the source of CK2. Alternatively, these kinase assays were performed using casein or GST fusion proteins encoding known protein substrates of CK2 in the presence of the indicated amounts of Pin1. For the latter assays, kinase assays were performed in buffer containing 50 mM Tris, pH 7.5, 10 mM MgCl 2 , 100 mM NaCl, 0.2 mM DTT, 100 M [␥- 32 P]ATP (specific activity 400 -1000 cpm/pmol) using each of the indicated proteins as substrate. Following incubation for 10 min at 30°C, kinase reactions were terminated by the additional SDS-PAGE sample buffer and boiling. Following SDS-PAGE, phosphorylated proteins were detected using a PhosphorImager.
Incorporation of 32 P into Topoisomerase II-The wild-type Y2C fragment of topoisomerase II␣ and the mutant form with the Thr-1342 to alanine substitution T1342A were produced in bacteria and then purified and blotted to polyvinylidene difluoride membrane as described above (33) . The membranes were blocked in 5% BSA in TBST. The blots were then treated in the following manner: washed twice with TBST, once with TEM, once with TEM with 0.5% Triton X-100, once with TEM with 25 M ATP and 200 nM microcystin LR, and then again with TEM. The blots were then incubated for 35 min at 37°C with mixing in TEM with 25 M ATP, 5 Ci [␥-32 P]ATP, 80 l of CK2-enriched FPLC fraction, 1.5 g/ml aprotinin, 10 g/ml leupeptin, 100 M PMSF, 1 mM DTT, and 200 nM microcystin with or without 50 g/ml heparin in a total volume of 3 ml. To terminate the reaction, the blots were washed three times with TEM with 10 mM EDTA, 20 mM NaF, and 0.1% Triton X-100 and once in TEM with 10 mM EDTA, 20 mM NaF. The blots were air-dried and visualized using a PhosphorImager.
RESULTS

Pin1
Interacts with Protein Kinase CK2-As a first step toward testing whether Pin1 could interact with CK2, recombinant Pin1 proteins were generated. GST and GST-Pin fusion proteins were produced in bacteria and purified using glutathione-agarose beads (not shown). GST-Pin1 or GST binding assays (i.e. pulldowns) were performed using U2OS cell lysates. To test whether CK2 interacts with Pin1, the proteins that bound to GST-Pin1 or GST were examined by immunoblotting with antibodies against CK2␣ (Fig. 1A) . CK2␣ was readily detected in both interphase and mitotic extracts (Fig. 1A) . In the mitotic extract, multiple ␣-bands are present with the bands of reduced electrophoretic mobility representing the phosphorylated forms of ␣ that have been characterized previously (26, 28, 29) . Because CK2␣ can be phosphorylated at up to 4 sites in mitotic cells, individual bands represent different phosphorylated forms of CK2 with the bands exhibiting the slowest electrophoretic mobility representing the most heavily phosphorylated forms of CK2␣. In binding assays, GST-Pin1 interacted strongly with mitotic CK2␣ but not with interphase CK2␣ (Fig. 1A) . It is also apparent that the most heavily phosphorylated form of CK2␣ exhibits the greatest interactions (Fig. 1A, last lane) . CK2␣ was not detected in the GST binding assays (Fig. 1A) indicating that the Pin1 portion of the GSTPin1 proteins is that which is required for interactions with CK2. Overall, these results indicate that Pin1 interacts with CK2.
Interactions between CK2 and Pin1 were also examined using transfected CK2. Cells were transfected with HA-tagged CK2␣ (designated ␣-HA) together with Myc-tagged wild-type CK2␤ and extracts prepared for examination of interactions with Pin1 (Fig. 1B) . As seen with CK2␣ from untransfected cells, Pin1 interacts with transfected CK2␣-HA with the greatest interaction observed with the CK2␣-HA from mitotic cells (Fig. 1B, last lane) . However, in contrast to the results observed with the endogenous CK2, transfected CK2␣-HA exhibits the appearance of multiple ␣-bands in interphase extracts in the transfected cell extracts suggesting that the CK2␣-HA is phosphorylated even without mitotic synchronization (Fig. 1B, 1st  lane) . We do not know the precise reason for the presence of these phosphorylated forms of CK2␣-HA, but we speculate that these extra interphase bands may be the result of aberrant cell cycle events induced by overexpression of CK2 or by the transfection procedure. Because some of the CK2␣-HA that is present in interphase extracts is phosphorylated, it is therefore not surprising that some CK2␣-HA is observed in the GST-Pin1 pulldown from interphase extracts (Fig. 1B, 2nd last lane) . In this pulldown, there is an obvious enrichment of the mostly heavily phosphorylated form of CK2␣-HA. Overall, the transfection experiments reinforce the suggestion that Pin1 preferentially interacts with phosphorylated CK2␣.
Comparison of Interactions between Pin1 and CK2␣ Versus CK2␣Ј-Significant differences between CK2␣ and CK2␣Ј are found only within their C-terminal regions (50) , and the mitotic phosphorylation sites on ␣ all lie within this region (26, 28) . CK2␣Ј does not have any of the mitotic phosphorylation sites and is not phosphorylated in mitotic cells. To determine whether CK2␣Ј could be transformed into a Pin1 interactor if it gained the mitotic phosphorylation sites of CK2␣, a chimeric construct of CK2␣Ј (designated ␣Ј/␣) with the C terminus of ␣Ј replaced by that of ␣ was used in GST-Pin1 binding assays (Fig.  2) . The addition of the C-terminal domain of CK2␣ to CK2␣Ј resulted in the appearance of multiple bands as seen with phosphorylated ␣ (Fig. 2) indicating that the ␣Ј/␣ chimera undergoes mitotic phosphorylation reminiscent of that seen with CK2␣. In pulldown assays, the CK2␣Ј/␣ chimera clearly exhibits interactions with GST-Pin1, whereas negligible interactions between GST-Pin1 and CK2␣Ј are observed under these conditions (Fig. 2B, compare last 2 lanes) . As well, no CK2 subunits were retained in GST binding assays (Fig. 2) . Clearly, the addition of the C-terminal domain of CK2␣ is capable of converting CK2␣Ј into a Pin1 interactor. It is also noteworthy that the transfections of CK2␣, CK2␣Ј, and CK2␣Ј/␣ were all performed in the presence of Myc-CK2␤. Consequently, because CK2␣Ј was not retained by GST-Pin1, it would appear that the ability of CK2 to interact with Pin1 resides in CK2␣ and not CK2␤. Figs. 1  and 2 demonstrate that phosphorylated forms of CK2␣ can be isolated from cell extracts using GST-Pin1. However, because the source of CK2 was soluble cell extracts, it was not possible to determine whether CK2␣ interacts directly with GST-Pin1 or whether the interaction between CK2 and Pin1 is mediated by other proteins that are present in cell extracts. Consequently, we performed experiments to determine whether CK2␣ can interact directly with Pin1 and to determine whether the C-terminal domain of CK2␣ is sufficient for interactions with Pin1. Pulldown assays were performed using a bacterially expressed GST fusion protein encoding the C-terminal 126 amino acids of CK2␣. This bacterially expressed fusion protein was purified and phosphorylated at the mitotic phosphorylation sites of CK2␣ by p34
Pin1 Interacts with a GST Fusion Protein Encoding the Cterminal 126 Amino Acids of CK2␣-Results shown in
Cdc2 using [␥-32 P]ATP (28) . As illustrated in Fig. 3 , this phosphorylated fusion protein exhibits interactions in pulldown assays with His-tagged Pin1 that had also been expressed and purified from bacteria. Notably, the amount of 32 P-labeled fusion protein that is retained by Histagged Pin1 immobilized on Ni-NTA resin is ϳ4 -5-fold above the background binding of this fusion protein that is observed using Ni-NTA resin alone or an unrelated His-tagged protein immobilized on Ni-NTA (Fig. 3, C and D) . These results demonstrate that the C-terminal domain of CK2␣ is sufficient for interactions with Pin1 and indicate that CK2␣ can interact directly with Pin1.
Examination of Interactions between Pin1 and Phosphorylation Site Mutants of CK2-By having demonstrated that the C-terminal domain of CK2␣ is sufficient for interactions with Pin1, further experiments were undertaken to examine directly the importance of phosphorylation for interactions of CK2 with Pin1. Cells were transfected with wild-type CK2␣ (␣-HA) or a mutant CK2␣ (␣4A-HA). CK2␣4A-HA is a mutant where each of the four mitotic phosphorylation sites of CK2␣ have been substituted with non-phosphorylatable alanines. Although wild-type CK2␣-HA appears as several bands exhibiting shifts in electrophoretic mobility resulting from phosphorylation, the ␣4A-HA mutant appears as a single band that co-migrates with , and an HA-tagged chimera comprising CK2␣Ј with the C-terminal domain of CK2␣ (CK2␣Ј/␣) were generated. As described under "Materials and Methods," CK2␣Ј/␣ was generated by replacing residues 297-351 of CK2␣Ј with residues 296 -391 of CK2␣. The mitotic phosphorylation sites of CK2␣ (i.e. Thr-344, Thr-360, Ser-362, and Ser-370) that are all located within this C-terminal region of CK2␣ are indicated (P). B, these constructs were transfected into U2-OS cells together with Myc-CK2␤ and examined for their ability to interact with GST or with GST-Pin1 (designated Pin1) as in Fig. 1 . Extracts were prepared from transfected cells that had been arrested in mitosis with nocodazole. Extracts as well as the proteins bound to GST or to GST-Pin1 (designated as Pin1) were separated by 12% SDS-PAGE, transferred to membranes, and analyzed on immunoblots using anti-HA antibodies. Molecular weight markers are also indicated (lane M).
non-phosphorylated CK2␣. Consistent with the prediction that phosphorylation is important for the interaction, ␣4A-HA was minimally retained on GST-Pin beads in comparison with mitotic wild-type ␣ in binding assays (Fig. 4A, compare last 2  lanes) . Neither ␣-HA nor ␣4A-HA were retained by GST beads (Fig. 4A) . In other experiments, this interaction was quantified using iodinated protein A as described under "Materials and Methods." There was 5-40-fold more wild-type ␣-HA than ␣4A-HA retained on GST-Pin1 beads. These results indicated that at least one of the mitotic phosphorylation sites of CK2␣ is important for its interactions with Pin1.
Next, the effect of replacing the phosphorylation sites of CK2␣ with glutamic acid or aspartic acid was examined. It was hypothesized that the negative charge of these amino acids might mimic the negative charge of phosphate groups and allow for interactions with Pin1. Cells were transfected with ␣4E-HA or ␣4D-HA together with Myc-␤, and again GST and GST-Pin1 binding assays were performed (Fig. 4B) . These two phosphorylation site mutants of CK2␣ bound far less effectively to the Pin1 beads relative to wild-type mitotic CK2␣ (Fig.  4B) . None of the proteins bound to GST beads (Fig. 4B, lanes  5-7) . Therefore, the negative charges provided by the glutamic and aspartic acids were not sufficient to mimic completely the phosphorylated serines and threonines on CK2␣ for Pin1 recognition.
The regulatory CK2␤ subunit of CK2 is also phosphorylated in mitotic cells at a Ser/Pro site (25, 27) . Therefore, to test whether phosphorylation of CK2␤ has an impact on interactions with Pin1, a similar strategy was used utilizing cells transfected with Myc-tagged wild-type ␤, or mutants of ␤ where serine 209 had been replaced with either alanine or with aspartic acid (i.e. ␤ S209A and ␤ S209D, respectively). Each of these constructs was transfected into cells along with CK2␣-HA, and pulldowns were performed. As seen in Fig. 4C (last 3  lanes) , there was no striking difference in the amount of ␤ and ␣ detected when GST-Pin1 binding assays were performed using these three different ␤ constructs, suggesting that phosphorylation of ␤ does not affect interactions of CK2 with GSTPin1. Of note is the predominance of the ␤-band with the higher mobility in GST-Pin binding assays. This band is autophosphorylated ␤ and is indicative of ␤ that is part of a tetrameric CK2 complex (19, 51, 52) , suggesting that ␤ is being pulled down as a part of a complex with ␣. Collectively, these results demonstrate that it is unlikely that the mitotic phosphorylation site on ␤ is important for interactions with Pin1.
FIG. 3. A GST fusion protein encoding the C-terminal domain of CK2␣ interacts with Pin1.
A GST fusion protein encoding the C-terminal 126 amino acids of CK2␣, designated GST-CK2␣-C126, was phosphorylated in vitro with purified p34
Cdc2 using [ 32 P]ATP. A and B, 32 P-labeled GST-CK2␣-C126 was examined for interactions with Histagged Pin1 that had been immobilized on Ni-NTA. 32 P-Labeled GST fusion protein that was retained on His-Pin1 was visualized with a PhosphorImager following electrophoretic separation. The input lanes represent the phosphorylated 32 P-labeled GST-CK2␣-C126 fusion proteins that were utilized for these interactions. As controls, the 32 Plabeled GST-CK2␣-C126 fusion protein was also examined for interactions with Ni-NTA resin alone (A) or with N70, an unrelated His-tagged fusion protein that represents an N-terminal fragment of SecA that had been immobilized on Ni-NTA (B). C and D, graphical representation of relative amounts of 32 P-labeled GST-CK2␣-C126 that were retained on each resin as determined by PhosphorImager analysis of scans illustrated in A and B, respectively.
FIG. 4. Examination of Pin1 interactions with phosphorylation site mutants of CK2.
A, wild-type CK2␣ (WT) and a mutant of CK2␣ with each of its four mitotic phosphorylation sites mutated to alanine (4A) were examined for interactions with GST or GST-Pin1 as in Figs. 1 and 2 using extracts derived from nocodazole-arrested cells. Extracts as well as the proteins bound to GST or to GST-Pin1 (designated as Pin1) were separated by 12% SDS-PAGE, transferred to membranes, and analyzed on immunoblots using anti-HA to detect either wild-type CK2␣ or the 4A mutant of CK2␣. The positions of phosphorylated wild-type CK2␣ (p-␣-HA) as well as non-phosphorylated wildtype CK2␣ (␣-HA) and the 4A mutant of CK2␣ (␣-4A-HA) are indicated. Non-phosphorylated wild-type CK2␣ (␣-HA) and the 4A mutant of CK2␣ (␣-4A-HA) exhibit similar electrophoretic mobility. B, the four mitotic phosphorylation sites on CK2␣ were mutated to glutamic acid (4E) or to aspartic acid (4D) to determine whether negatively charged amino acids could mimic phosphorylation in terms of interactions with Pin1. Extracts prepared from transfected cells arrested in mitosis as well as the proteins bound to GST or to GST-Pin1 (designated as Pin1) were separated by 12% SDS-PAGE, transferred to membranes, and analyzed on immunoblots using anti-HA to detect the wild-type and mutant forms of CK2␣. Phosphorylated wild-type CK2␣ exhibits similar electrophoretic mobility to that of either the 4E or the 4D mutants. C, Ser-209, the mitotic phosphorylation site on CK2␤ was mutated to either alanine (designated A 209 ) or to aspartic acid (designated D
209
) to determine whether alteration in the phosphorylation of CK2␤ would affect interactions between CK2 and Pin1. Extracts as well as the proteins bound to GST or to GST-Pin1 (designated as Pin1) were separated by 12% SDS-PAGE, transferred to membranes, and analyzed on immunoblots using anti-HA to detect CK2␣ϪHA and anti-Myc to detect wild-type (WT) or phosphorylation site mutants of CK2␤. The positions of CK2␣-HA (␣-HA) and its phosphorylated form (p-␣-HA) as well as Myc-CK2␤ (Myc-␤) and its autophosphorylated form (p-Myc-␤) are also indicated. Note that mutation of Ser-209 does not affect the electrophoretic mobility of Myc-␤.
In summary, the importance of phosphorylation of CK2 for Pin1 interaction was demonstrated. Elimination of mitotic phosphorylation sites on ␣ diminished its interactions with Pin1, and the elimination of the mitotic phosphorylation site on ␤ did not have a significant effect. Furthermore, ␣Ј could be transformed into a Pin1-interacting protein with the addition of the C-terminal domain of ␣ containing the mitotic phosphorylation sites.
Examination of Interactions between CK2␣ and Pin1 Using Pin1 Mutants-Pin1 is composed of a WW domain that exhibits phosphorylation-dependent interactions with target proteins as well as a peptidylprolyl isomerase domain that exhibits phosphorylation-dependent catalytic activity (30, 37) . To examine the role of each of these domains for binding CK2␣, binding assays were performed with various Pin1 mutants (Fig. 5) . By itself, the isomerase domain of Pin1 designated GST-Pin1 did not bind CK2␣-HA (Fig. 5, 4th lane) . By comparison, GSTPin1 1-54 encoding only the WW domain of Pin1 did exhibit interactions with CK2␣-HA (Fig. 5, 5th lane) . Similarly, GSTPin1 Y23A , a mutant that abolishes the binding activity of the WW domain (37) did not bind CK2␣-HA, whereas GSTPin1 R68A,R69A , a mutant reported to diminish significantly isomerase activity (9, 31) did bind CK2␣-HA (Fig. 5) . Overall, these results suggest that the WW domain is most important for binding CK2␣-HA. However, the interactions between the WW domain and CK2␣-HA appeared to be much weaker than those observed with wild-type full-length Pin1 with CK2␣-HA. Although we have not rigorously excluded the possibility that other regions of Pin1 are important for interactions with CK2␣, the importance of the WW domain is consistent with evidence indicating that this protein interaction module is essential for the cellular functions of Pin1.
Examination of the Effects of Pin1 on CK2 Activity-To determine whether Pin1 affects the catalytic activity of CK2, we examined the effect of Pin1 on the ability of CK2 to phosphorylate peptide and protein substrates. As seen in Fig. 6 , Pin1 at various concentrations does not exert any dramatic effect on the in vitro activity of CK2 toward an optimized peptide substrate (Fig. 6A) nor toward known CK2 substrates such as casein (Fig. 6B) , GST-Max (Fig. 6C) , or a GST fusion protein encoding a portion of c-Myb that contains residues known to be phosphorylated by CK2 (Fig. 6D) (53) . Similarly, Pin1 had no effect on the phosphorylation of a GST fusion protein encoding a portion of c-Myc that contains known CK2 phosphorylation sites (data not shown). Collectively, these results indicate that Pin1 is not a general inhibitor of CK2.
Although CK2 is active at all stages in the cell cycle (29) , there is evidence that the activity of CK2 toward specific substrates could be modulated at specific stages during the cell cycle. For example, CK2 was recently shown to phosphorylate residues on topoisomerase II␣ that are maximally phosphorylated in mitotic cells (33, 34) . These observations strongly suggest that topoisomerase II␣ is a mitotic target of CK2 in mammalian cells. Studies with temperature-sensitive mutants of CK2 in yeast provide similar indications that topoisomerase II is also a mitotic target for CK2 in yeast (31). Because we have previously shown that CK2 is phosphorylated in mitotic cells (26, 28) and because Pin1 interacts preferentially with mitotic CK2 and has been implicated in the control of mitotic events, we were thus interested in examining the effects of Pin1 on the CK2-catalyzed phosphorylation of the mitotic phosphorylation sites on topoisomerase II␣. To achieve this objective, we utilized a recombinant fragment of topoisomerase II␣, designated Y2C, as a substrate for CK2. The Y2C fragment of topoisomerase II used in this study is the fragment of topoisomerase II␣ encoding residues 1158 -1362. This fragment was previously utilized for the identification of Thr-1342 as the phosphorylated residue on topoisomerase II␣ that is recognized by the 3F3/2 monoclonal antibodies (33) . Furthermore, topoisomerase II␣ can be immunoprecipitated from mitotic cells using 3F3/2 monoclonal antibodies, and CK2 phosphorylation can generate 3F3/2 reactivity on topoisomerase II␣ that is associated with isolated chromosomes (33) . Consequently, it appears that Thr- FIG. 5 . Examination of interactions between CK2 and Pin1 mutants. To identify the region of Pin1 that interacts with CK2, several GST-Pin1 mutant proteins were used in pulldown assays. Extracts as well as the proteins bound to GST or to the various GST-Pin1 fusion proteins were separated by 12% SDS-PAGE, transferred to membranes, and analyzed on immunoblots using anti-HA antibodies to detect epitope-tagged CK2␣ (␣-HA). In addition to GST-Pin1, the following mutant proteins were utilized: GST-Pin1 which encodes the isomerase domain of Pin1, GST-Pin1 1-54 which represents the WW domain of Pin1, GST-Pin1
Y23A which encodes full-length Pin1 with an inactivating mutation within its WW domain, and GST-Pin1 R68A,R69A which encodes full-length Pin1 with an inactivating mutation within its isomerase domain. Pulldowns were performed as in previous figures using extracts of cells that had been transfected with HA-tagged CK2␣ and arrested in mitosis with nocodazole. HA-tagged CK2␣ was detected using chemiluminescence. The pulldown with GST-Pin1 represents half as much volume as was loaded for each of the other pulldowns.
FIG. 6.
Pin1 is not a general inhibitor of CK2. CK2 fractions that had been isolated by FPLC from mitotic cell extracts as described under "Materials and Methods" were examined for their ability to phosphorylate known CK2 substrates including the synthetic peptide RRRD-DDSDDD (A), casein (B), GST-Max (C), and a GST fusion protein designated GST-Myb that encodes the N-terminal 198 amino acids of c-Myb (D). Phosphorylation of the synthetic peptide was performed using a P81 filter assay as described under "Materials and Methods" in the presence of the indicated concentrations of GST (open bars) or GST-Pin1 (solid bars). Phosphorylation of casein, GST-Max, and GSTMyb was similarly performed in the presence of the indicated concentrations of Pin1. 32 P incorporation into casein, GST-Max, and GST-Myb was detected using a PhosphorImager.
1342 is indeed phosphorylated in mitotic cells and that CK2 can phosphorylate this residue in intact topoisomerase II␣ and in the Y2C fragment.
The 3F3/2 monoclonal antibody was utilized to assay for phosphorylation of one of the mitotic sites (i.e. Thr-1342) of topoisomerase II␣ by partially purified mitotic CK2 (Fig. 7) . The CK2 utilized in these studies was partially purified from mitotic extracts utilizing ion exchange chromatography as described under "Materials and Methods." Partial purification was performed to separate CK2 from many of the other protein kinase or phosphatase activities in extracts that could confound the examination of CK2 activity. It is evident that the wild-type Y2C fragment of topoisomerase II␣ was readily phosphorylated by CK2, whereas the same topoisomerase II fragment with Thr-1342 mutated to alanine was negligibly detected (Fig. 7A) . This result is consistent with previous findings (33) . Additionally, assays were performed in the absence of CK2 or ATP. In either case, no bands were detected with the 3F3/2 antibody (data not shown). These control assays further confirmed that the antibody was sensitive to phosphorylation.
Because topoisomerase II is multiply phosphorylated and a potential target for kinases distinct from CK2 (31, 54 -57), we also performed experiments to determine whether the Y2C fragment was phosphorylated by kinases other than CK2 present in the FPLC fraction. As seen in Fig. 7B , the CK2 inhibitor heparin completely abolished the incorporation of 32 P into both the wild-type and Thr-1342/Ala mutant Y2C fragments. This result suggests that no other kinases were present and phosphorylating the topoisomerase II fragment to any appreciable extent. Comparison of the wild-type Y2C topoisomerase II␣ fragment with the Thr-1342/Ala mutant topoisomerase II␣ fragment indicates that residues in addition to Thr-1342 are phosphorylated by CK2 (Fig. 7B) . By utilizing the 3F3/2 antibody to examine the phosphorylation of Thr-1342, we examined the effect of GST-Pin1 on the ability of CK2 to phosphorylate this residue. A dose-dependent inhibition of Thr-1342 phosphorylation by CK2 was clearly observed (Fig. 7C) . By comparison, the addition of GST generated no inhibition of Thr-1342 phosphorylation. Thus, Pin1 can inhibit the phosphorylation of Thr-1342 on topoisomerase II␣ by CK2.
Investigation of the Mechanism by Which Pin1 Inhibits Phosphorylation of Topoisomerase II␣ by CK2-The peptidylprolyl isomerase activity of Pin1 is essential for its in vivo functions (9, 30) . Consequently, there has been considerable speculation that Pin1 does indeed catalyze conformational changes in at least some of its target proteins. However, for the most part, direct evidence for Pin1-catalyzed conformational changes in its target proteins has not been obtained. One exception is the cell cycle regulatory phosphatase Cdc25 (58, 59) . Lines of evidence demonstrating that Cdc25 undergoes conformational changes include the fact that its dephosphorylation by protein phosphatase 2A is affected by catalytic amounts of Pin1 (58) . Similarly, recognition of Cdc25 by phosphospecific MPM-2 monoclonal antibodies is affected by Pin1 (59) . Based on these studies, we performed experiments to examine the ability of Pin1 to alter the reactivity of CK2 toward MPM-2 monoclonal antibodies or to affect the dephosphorylation of CK2 by protein phosphatase 2A. However, unlike Cdc25, protein phosphatase 2A was ineffective at the dephosphorylation of CK2 either with or without Pin1 treatment (data not shown). In a similar vein, CK2␣ was not recognized by MPM-2 antibodies in the presence or absence of Pin1 (not shown). Because these strategies, which were employed successfully to monitor conformational changes in Cdc25, were not amenable for an examination of CK2, we performed a number of additional studies to obtain mechanistic insights into the manner in which Pin1 inhibits the phosphorylation of topoisomerase II␣ by CK2.
Because Pin1 interacts with CK2 in a phosphorylation-dependent manner, we were interested in determining whether the inhibition of Thr-1342 phosphorylation resulted solely from phosphorylation-dependent interactions between CK2 and Pin1. To achieve this objective, we compared interphase CK2 to mitotic phosphorylated CK2 in the Thr-1342 phosphorylation assay. Extracts from interphase or mitotic cells were fractionated by FPLC (Fig. 8) . Immunoblots were probed with anti-␣ antibodies to ensure that mitotic ␣ was phosphorylated (Fig.  8A) , and kinase assays were performed to determine the amount of CK2 kinase activity in each fraction (Fig. 8B) . As illustrated in Fig. 8C , Pin1 exhibits a similar degree of inhibition of Thr-1342 phosphorylation with CK2 from mitotic and interphase fractions. This result suggests that the inhibition of Thr-1342 phosphorylation is not exclusively the result of phosphorylation-dependent interactions between CK2 and Pin1.
To explore further the mechanism by which Pin1 inhibits the phosphorylation of topoisomerase II by CK2, we were interested in testing the possibility that topoisomerase II also interacts with Pin1, as has been suggested previously (30, 34) . To achieve this objective, pulldown assays were performed to determine whether topisomerase II␣ obtained from interphase or mitotic cells can interact with GST-Pin1. As seen in Fig. 9 , a band of ϳ175,000 daltons recognized by anti-topoisomerase II␣ antibodies is observed in interphase nuclear extracts or in mitotic chromosome preparations and in pulldowns using GSTPin1 but not GST. It is evident that the amount of topoisomer- FIG. 7 . Pin1 inhibits the phosphorylation of Thr-1342 on topoisomerase II␣ by CK2. Phosphorylation of Thr-1342 within the Y2C fragment of topoisomerase II␣ was monitored using the phospho-specific 3F3/2 antibody as described under "Materials and Methods." A, wild-type Y2C fragment of topoisomerase II (wt) as well as a mutant form of the Y2C fragment that harbors a substitution of Thr-1342 with alanine (i.e. T1342A) were incubated with CK2 and ATP prior to detection on immunoblots with 3F3/2 antibodies. For this experiment, CK2 was partially purified by FPLC from extracts derived from asynchronously growing cells as described under "Materials and Methods." B, CK2 was partially purified by FPLC from extracts derived from cells arrested in mitosis as described under "Materials and Methods" and used to phosphorylate wild-type Y2C or T1342A mutant Y2C fragment of topoisomerase II␣ using [
32 P]ATP in the presence or absence of the CK2 inhibitor heparin as indicated. Phosphate incorporation into Y2C fragments was detected using a PhosphorImager. C, phosphorylation of Thr-1342 within the wild-type Y2C fragment of topoisomerase II␣ by partially purified CK2 was performed as in A in the presence of increasing amounts of GST or GST-Pin1 (as indicated) and detected on an immunoblot using the 3F3/2 monoclonal antibody. Partially purified mitotic CK2 was prepared as in B.
ase II␣ isolated from mitotic cells exceeds that observed in interphase cells, consistent with the possibility that mitotic phosphorylation of topoisomerase II␣ also enhances its interactions with Pin1. However, a direct examination of whether the phosphorylation of topoisomerase II␣ is indeed required for optimal interactions with Pin1 has not been examined in this study because the focus of our investigation has been on the interactions between Pin1 and CK2. Overall, these results indicate that topoisomerase II␣ also interacts with Pin1 and suggests that it is indeed possible that interactions between topoisomerase II and Pin1 contribute to the inhibition of Thr-1342 phosphorylation that is observed.
Additional studies to elucidate the mechanism by which Pin1 inhibits the CK2-catalyzed phosphorylation of topoisomerase II␣ were focused on an investigation of the role of the individual domains of Pin1. As illustrated in Fig. 10 , full-length wildtype Pin1 is the most potent inhibitor of topoisomerase II␣ phosphorylation. By comparison, deletion mutants and point mutants that have been described to abolish either the binding activity of the WW domain or the catalytic activity of the isomerase domain (30, 37) result in a dramatic decrease in inhibitory activity as compared with full-length wild-type Pin1. Overall, these results suggest that the inhibition of topoisomerase II␣ phosphorylation requires both the protein binding activity of the WW domain and the cis-trans isomerization of peptidyl-prolyl bonds within CK2 or topoisomerase II␣.
DISCUSSION
Pin1 interacts with a number of mitotic phosphoproteins involved in the cell cycle (8 -10) , and on the basis that CK2 is phosphorylated at Ser/Pro and Thr/Pro sites in mitotic cells (25) (26) (27) (28) , we hypothesized that Pin1 may interact with CK2 in a phosphorylation-dependent manner. By using GST-Pin1 binding assays, interactions between Pin1 and CK2 were indeed detected. When comparing binding of Pin1 to interphase and mitotic CK2, far more mitotic CK2 interacted with Pin1 based on the intensity of bands on blots from the binding assays. Results comparing wild-type CK2␣ to the CK2␣4A mutant, which has the four mitotic phosphorylation sites of CK2␣ mutated to alanines, showed a dramatic decrease in interactions between Pin1 and CK2. Lending further weight to the conclusion that phosphorylation is important for the interactions between CK2 and Pin1 is the observation that CK2␣Ј can be converted into a Pin1-interacting protein when its C terminus is replaced by that of CK2␣ (Fig. 2) .
The mutation of the mitotic phosphorylation sites on CK2␣ to aspartic acids and glutamic acids was performed to mimic a permanent phosphorylation state by the addition of these negatively charged residues. However, in comparison to the wildtype mitotic CK2␣, these mutants were poor interactors with Pin1. Consequently, it would appear that the negative charge alone is not sufficient for Pin1 recognition. This result concurs with the findings of Yaffe et al. (30) who found that Glu-Proand Asp-Pro-containing peptides were isomerized by Pin1 at a slower rate than phosphorylated Ser-Pro-containing peptides. Thus, glutamic and aspartic acids do not appear to be effective substitutes for phosphorylated serines and threonines in terms of Pin1 recognition.
It is generally accepted that CK2 is a tetrameric enzyme composed of two catalytic CK2␣ and/or CK2␣Ј subunits and two regulatory CK2␤ subunits. Previous studies (43) indicate that tetrameric complexes can be composed of identical catalytic ) . Following DNase treatment, the topoisomerase II␣ in these preparations was examined for interactions with GST or GST-Pin1 as in previous figures. The input as well as the proteins bound to GST or to GST-Pin1 (designated as Pin1) were separated by 6% SDS-PAGE, transferred to membranes, and analyzed on immunoblots using anti-topoisomerase II␣ antibodies (AB-1) with chemiluminescent detection. The position of the 175,000 molecular weight marker is indicated. subunits (i.e. two CK2␣ subunits or two CK2␣Ј subunits in complexes with two CK2␤ subunits). Alternatively, tetrameric CK2 complexes can be composed of one CK2␣ subunit and one CK2␣Ј subunit together with two CK2␤ subunits (43) . In this study, CK2␤ was consistently detected in GST-Pin1 binding assays whenever CK2␣ was detected. The presence of CK2␤ in pulldowns with GST-Pin1 may simply result from the association of CK2␤ with CK2␣. Alternatively, because CK2␤ is also phosphorylated at a Ser/Pro site in mitotic cells (25) , it is possible that direct interactions between CK2␤ and Pin1 may contribute to the interactions between CK2 and Pin1. However, there are two lines of evidence that suggest that CK2␤ does not interact with Pin1. First of all, when CK2␣Ј is co-expressed with CK2␤ (Fig. 2) , there is no evidence of interactions between CK2␣Ј and Pin1 indicating that CK2␤ is not sufficient to mediate interactions between Pin1 and CK2. Furthermore, as shown in Fig. 4 , the substitution of Ser-209 of CK2␤ by alanine or glutamic acid resulted in no dramatic change in the amount of CK2 detected in the binding assays. Therefore, it would appear that if Pin1 does interact with CK2␤ directly it does so in a phosphorylation-independent manner. More likely, CK2␤ is involved indirectly with Pin1 via its interactions with ␣ in tetrameric CK2 complexes, a suggestion that is supported by the observation that the autophosphorylated form of CK2␤ is predominantly seen in the binding assays (Fig. 4C) . Importantly, autophosphorylation of CK2␤ appears to be an indicator that CK2␤ is in a complex with the CK2 catalytic subunits (35, 51, 52) . Collectively these results indicate the importance of the phosphorylation of CK2␣, not CK2␤, for interactions with GSTPin1. In a related vein, we have also demonstrated that the C-terminal domain of CK2␣ is sufficient for interactions with Pin1 (Fig. 3) . Consequently, in addition to tetrameric CK2 complexes that contain CK2␣, it is possible that CK2␣ that is not in tetrameric CK2 complexes could also be interacting with Pin1 in pulldown assays.
Our results indicate that the WW domain of Pin1 by itself, as well as full-length Pin1 deficient in isomerase activity, retained some ability to interact with CK2. The ability of the WW domain alone to bind Pin1 target proteins has been observed with a number of other proteins including Cdc25, Plk1, and Cdc27 (37) . However, in this study, less CK2 was pulled down using these mutant forms of Pin1 than with the full-length functional Pin1. These results suggest that both domains are important for optimal interactions between Pin1 and CK2.
Pin1 and CK2 interact in a manner dependent on the mitotic phosphorylation of CK2. This suggests that their interaction may play a role in events during mitosis. Given the massive burst of phosphorylation of proteins in mitosis, one might propose that Pin1 may modulate how CK2 phosphorylates proteins necessary for mitotic events to occur. This line of reasoning led to an examination of the effect of Pin1 on the ability of CK2 to phosphorylate a mitotic CK2 substrate. In mammalian cells, topoisomerase II is highly phosphorylated during G 2 and mitosis and seemed like an ideal candidate to examine, because it was recently demonstrated that Thr-1342, which is phosphorylated in vitro by CK2, is maximally phosphorylated in mitotic cells (32, 33) . Additionally, in yeast with temperature-sensitive CK2, topoisomerase II is hypophosphorylated at the non-permissive temperature (31) . To test the effects of Pin1 on the phosphorylation of Thr-1342 by CK2, we utilized the 3F3/2 phosphoepitope detection assay devised by Daum and Gorbsky (33) . For reasons that remain elusive, detection of the phosphoepitope was not consistently observed in every experiment. In some experiments, minimal CK2-catalyzed phosphorylation of Thr-1342 was detected suggesting that there was a failure of CK2 to phosphorylate Thr-1342 or that there was a failure of the 3F3/2 antibody to detect the phosphorylated residue. These results suggest that CK2 and/or 3F3/2 may be sensitive to the conformation of Thr-1342 on the polyvinylidene difluoride membrane. Nevertheless, the dose-dependent inhibition of CK2-catalyzed phosphorylation of Thr-1342 by Pin1 was observed in five independent experiments. Moreover, in no instance did the addition of Pin1 result in increased phosphorylation of Thr-1342, and in no instance did GST yield inhibition of Thr-1342 phosphorylation. Importantly, the decrease in CK2-catalyzed phosphorylation of Thr-1342 occurred in a concentration-dependent manner over the tested range of 0.1 to 2 M GST-Pin1 which is within the physiological concentration range proposed for Pin1 (9) . It is also notable that overexpression of Pin1 results in a G 2 arrest (1, 9) . In fact, this observation would be consistent with our finding in this paper which shows that Pin1 inhibits the ability of CK2 to phosphorylate topoisomerase II␣, one of its mitotic targets. Additionally, the Pin1-mediated inhibition of CK2-catalyzed phosphorylation of topoisomerase II␣ appears to be specific for topoisomerase II because the phosphorylation of other CK2 substrates including casein, c-Myb, Max, and an optimized CK2 peptide substrate was not affected by the presence of Pin1.
Because Pin1 preferentially interacts with mitotic CK2, we predicted that Pin1 would be less effective at inhibiting interphase CK2 in the Thr-1342 phosphorylation assay if the effect of Pin1 were exclusively directed at the phosphorylated residues of CK2. Because the phosphorylation of Thr-1342 by interphase and mitotic CK2 showed equal inhibition by Pin1 (Fig.  8 ), it appears that the inhibition of Thr-1342 phosphorylation by CK2 is complex and does not result simply through interactions with mitotic CK2␣. Therefore, to explore further the mechanism by which Pin1 inhibits the CK2-catalyzed phosphorylation of Thr-1342, we investigated the possibility that Pin1 also interacts with topoisomerase II using GST-Pin1 pulldown assays. This interaction may at least in part contribute to the effects of Pin1 on the phosphorylation of topoisomerase II by CK2. Although many details remain to be resolved, it is tempting to speculate how Pin1 may regulate CK2 and its ability to phosphorylate topoisomerase II␣. The findings of this study suggest that interactions with Pin1, and perhaps Pin1-catalyzed isomerization of CK2, may have an impact on the substrate preference of CK2 at least in the case of topoisomerase II. Our demonstration that Pin1 interacts with mitotic phosphorylated forms of CK2 and also with topoisomerase II␣ adds additional potential levels of control to the interactions between CK2 and topoisomerase II and phosphorylation of the latter.
Because it has the ability to interact with CK2 and with topoisomerase II, Pin1 may have the ability to modulate interactions between these two proteins. There is evidence from the work of others that Pin1 does indeed change the ability of its targets to interact with other proteins (10, 60) . For example, the association of phosphorylated Tau with microtubules occurs only after preincubation with Pin1 (60) . Mutation of the isomerase domain of Pin1 led to a decreased ability of Pin1 to facilitate phosphorylated Tau-mediated stabilization of microtubule assembly (60) providing indirect evidence that Pin1 catalyzes conformational changes on Tau. In other instances, it appears that the binding of Pin1 to a target, without catalyzing isomerization, is sufficient to exert an effect. For example, Pin1 caused a decrease in the p9-mediated stimulation of Cdc25 and Myt1 phosphorylation catalyzed by the Cdc2-cyclin B complex (10) . Catalytically inactive Pin1 was capable of exerting this inhibition suggesting that interactions between Pin1 and Cdc25 and Myt1 were responsible for the observed inhibition (10) . In the case of CK2 and topoisomerase II␣, there is additional complexity because our results demonstrate that both of these proteins can interact with Pin1. Furthermore, several studies have demonstrated that CK2 physically interacts with topoisomerase II in mammalian cells and in yeast, although controversy regarding the relationship of CK2 to the regulation of topoisomerase II remains (31) (32) (33) (34) (61) (62) (63) . Clearly, additional studies beyond the scope of this present work will be required to fully illuminate the precise role of Pin1 in the regulation of CK2 and topoisomerase II␣.
An important observation in this study is that Pin1 interacts with CK2 in a phosphorylation-dependent manner because it is the first report of an interaction involving the mitotic phosphorylated form of CK2. Additionally, these results provide further evidence for functional and perhaps regulatory differences between CK2␣ and CK2␣Ј. Functional and/or regulatory differences between these two catalytic isoforms of CK2 are in keeping with the high degree of conservation of CK2␣ and CK2␣Ј that is observed between species and the conservation of the mitotic phosphorylation sites on CK2␣ (50, 64) . Clearly, the precise functional role of this interaction between CK2 and Pin1, which both have key roles in the cell cycle, is an intriguing question that requires further attention. In vitro, Pin1 can inhibit the phosphorylation of Thr-1342 of topoisomerase II by CK2. However, given the complex nature of the possible interactions of Pin1 with CK2 and/or topoisomerase II, the precise manner in which Pin1 exerts this inhibition remains to be elucidated. Nevertheless, the ability of Pin1 to modulate selectively the substrate specificity of CK2 represents an important new mechanism for the regulation of CK2. In a similar vein, the recent studies of Keller et al. (65) suggest that the FACT complex plays a similar role in selectively modulating the ability of CK2 to phosphorylate p53 in response to DNA damage. In addition to the implications for CK2, the fact that Pin1 interacts with topoisomerase II and affects its phosphorylation by CK2 may have novel regulatory significance for topoisomerase II.
